Clinical Research of 18F-Alfatide Ⅱ PET/CT in Breast Cancer

• Status: Terminated
• Trial end date: 2019-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

18F-Alfatide Ⅱ PET/CT in breast cancer patients

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Jiang Wu

Criteria

Inclusion Criteria:

• The patients have been suspected or diagnosed with breast cancer and they have not received any treatment; It must fulfill the ethical requirements and subjects have signed an informed consent.

Exclusion Criteria:

• Pregnancy or nursing mothers; Those patients accompanied by other serious diseases such as cardiac functional insufficiency, hepatic and renal function insufficiency.